Items where Author is "Davidson-Moncada, JK"

Journal article

VADAKEKOLATHU, J., LAI, C., REEDER, S., CHURCH, S.E., HOOD, T., LOURDUSAMY, A., RETTIG, M.P., ALDOSS, I., ADVANI, A.S., GODWIN, J., WIEDUWILT, M.J., ARELLANO, M., MUTH, J., YAU, T.O., RAVANDI, F., SWEET, K., ALTMANN, H., FOULDS, G.A., STÖLZEL, F., MIDDEKE, J.M., CICIARELLO, M., CURTI, A., VALK, P.J.M., LÖWENBERG, B., GOJO, I., BORNHÄUSER, M., DIPERSIO, J.F., DAVIDSON-MONCADA, J.K. and RUTELLA, S., 2020. TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML. Blood Advances, 4 (20), pp. 5011-5024. ISSN 2473-9529

UY, G.L., ALDOSS, I., FOSTER, M.C., SAYRE, P.H., WIEDUWILT, M.J., ADVANI, A.S., GODWIN, J.E., ARELLANO, M.L., SWEET, K., EMADI, A., RAVANDI, F., ERBA, H.P., BYRNE, M., MICHAELIS, L.C., TOPP, M.S., VEY, N., CICERI, F., CARRABBA, M.G., PAOLINI, S., HULS, G., JONGEN-LAVRENCIC, M., WERMKE, M., CHEVALLIER, P., GYAN, E., RÉCHER, C., STIFF, P., PETTIT, K., LÖWENBERG, B., CHURCH, S., ANDERSON, E.K., VADAKEKOLATHU, J., SANTAGUIDA, M.T., RETTIG, M.P., MUTH, J., CURTIS, T., FEHR, E., GUO, K., ZHAO, J., BAKKACHA, O., JACOBS, K., TRAN, K., KAMINKER, P., KOSTOVA, M., BONVINI, E., WALTER, R.B., DAVIDSON-MONCADA, J.K., RUTELLA, S. and DIPERSIO, J.F., 2020. Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia. Blood. ISSN 0006-4971

RUTELLA, S., CHURCH, S.E., VADAKEKOLATHU, J., VIBOCH, E., SULLIVAN, A.H., HOOD, T., WARREN, S.E., CESANO, A., LA MOTTE-MOHS, R., MUTH, J., LELIÈVRE, H., LOWENBERG, B., DIPERSIO, J.F. and DAVIDSON-MONCADA, J.K., 2018. Adaptive immune gene signatures correlate with response to flotetuzumab, a CD123 × CD3 bispecific Dart® molecule, in patients with relapsed/refractory acute myeloid leukemia. Blood, 132 (S1): 444. ISSN 0006-4971

UY, G.L., RETTIG, M.P., VEY, N., GODWIN, J., FOSTER, M.C., RIZZIERI, D.A., ARELLANO, M.L., TOPP, M.S., HULS, G., JONGEN-LAVRENCIC, M., MARTINELLI, G., PAOLINI, S., CICERI, F., CARRABBA, M.G., SWEET, K.L., RAVANDI, F., CHURCH, S.E., VADAKEKOLATHU, J., RUTELLA, S., SUN, J., YANG, K., BAUGHMAN, J., CURTIS, T., TIMMENY, E., CALI, K., TRAN, K., MUTH, J., LA MOTTE-MOHS, R., POIROT, C., PALLIS, A., CESANO, A., BONVINI, E., WIGGINGTON, J., LOWENBERG, B., DAVIDSON-MONCADA, J.K. and DIPERSIO, J.F., 2018. Phase 1 cohort expansion of flotetuzumab, a CD123×CD3 bispecific Dart® protein in patients with relapsed/refractory acute myeloid leukemia (AML). Blood, 132 (S1): 764. ISSN 0006-4971